Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,926,036
+$17,280,054 QoQ
Shares Held
2,136,149
+189.7% QoQ
Ownership
3.39%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. QURE ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in QURE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,926,036 | 2,136,149 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,645,982 | 737,400 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,762,645 | 458,500 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $9,125,283 | 1,347,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,852,493 | 2,064,455 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,658,654 | 2,064,455 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $41,578,123 | 2,064,455 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,617,071 | 1,747,555 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,959,720 | 1,597,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,307,185 | 874,849 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $16,610,829 | 919,249 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,144,804 | 585,574 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,744,223 | 585,574 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,512,159 | 471,174 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $32,648,271 | 969,079 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,012,824 | 969,079 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $35,691,179 | 969,079 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $43,666,699 | 969,079 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $46,689,803 | 983,979 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||